Novartis AG (NOVN) won U.S. approval to market its cancer drug Afinitor for breast tumors, an achievement that may add more than $1 billion in annual sales. Afinitor was cleared for breast cancer patients whose...

A diabetes drug costing as  little as 2p a tablet could offer a major breakthrough in the treatment of prostate cancer. Research has shown that the medicine, called metformin, causes tumours to...

WASHINGTON — The Food and Drug Administration has approved Arena Pharmaceutical’s anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade....

Utter confusion could result if the Supreme Court invalidates the Affordable Care Act’s (ACA) individual mandate while upholding other parts of the law, a physician expert predicted ahead of Thursday’s expected decision....